Skip to content
PRAXIS

02.4Healthcare & Medical

Digital health

Digital health has to clear two bars at once — real clinical value and a viable business model — in a market where the buyer, the user, and the payer are often three different parties.

The terrain

What actually decides outcomes here.

Digital-health companies operate at the hardest intersection in the sector: they have to demonstrate genuine clinical outcomes and build a sustainable business, often while navigating a buyer (a health system or employer), a user (a patient), and a payer (an insurer) who are three separate parties with three sets of incentives. Product excellence alone doesn't resolve that; strategy does.

The graveyard is full of clinically promising companies that never solved the business model or the go-to-market. We help digital-health companies find the reimbursement or enterprise path that makes the model work, sharpen the evidence and positioning, and decide which customer to build for first.

Practice
Healthcare & Medical
Taxonomy
02.4
Reach
Worldwide

The hard calls

Where the decisions get expensive.

  1. 01

    The three-party market problem

    The buyer, user, and payer are often different, with different incentives. We help design the go-to-market around who actually pays and why, rather than assuming the user is the customer.

  2. 02

    Clinical evidence as the price of entry

    Without credible outcomes data, enterprise and payer doors stay shut. We help sequence evidence generation to the buying decisions it needs to unlock.

  3. 03

    Reimbursement or enterprise — pick the wedge

    The viable path is usually reimbursement, an employer channel, or an enterprise health-system sale. We help choose the wedge and build the motion for it rather than chasing all three.

  4. 04

    Retention and engagement as the model

    Health outcomes and business outcomes both depend on sustained engagement. We help make engagement a strategic design problem, not a feature.

Questions

Before you reach out.

We have great engagement but no revenue model — can you help?
That's one of the most common and most solvable problems here. The work is finding who genuinely pays — payer, employer, or health system — and building the evidence and motion to reach them, rather than assuming engagement converts on its own.
Do you validate clinical efficacy?
No — clinical validation is your clinical team's and your trials' job. We help make sure the evidence you generate is sequenced and positioned to unlock the buying decisions that make the business work.

Bring us a digital health decision.

A first conversation is a scoping conversation — no obligation, no packaged pitch. Tell us what you're deciding, and we'll tell you honestly whether we're the right firm for it.

No obligation · a scoping conversation first